Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1601 to 1650 of 2555

TitleReference numberPublishedLast updated
Cerebral palsy in under 25s: assessment and managementNG62
Antimicrobial stewardship: changing risk-related behaviours in the general populationNG63
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Boston Keratoprosthesis Type I for corneal blindnessMIB91
CentriMag for heart failureMIB92
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysisMIB93
Refractory extrapulmonary sarcoidosis: infliximabES4
Smartinhaler for asthmaMIB90
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
TuberculosisQS141
Learning disability: identifying and managing mental health problemsQS142
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135
Extracorporeal shockwave therapy for Achilles tendinopathyHTG426
Radiation therapy for early Dupuytren's diseaseHTG427
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Pulmonary sarcoidosis: infliximabES2
Oral health promotion in the communityQS139
Hypothermia: prevention and management in adults having surgeryCG65
Epiduroscopic lumbar discectomy through the sacral hiatus for sciaticaHTG425
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420
XprESS multi sinus dilation system for treating chronic sinusitisHTG424
CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubesMIB48
Mental wellbeing and independence for older peopleQS137
Transition between inpatient hospital settings and community or care home settings for adults with social care needsQS136
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosisCG95
Coexisting severe mental illness and substance misuse: community health and social care servicesNG58
Spasticity in under 19s: managementCG145
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventionsMIB89
OCS Heart system for heart transplantMIB86
CytoSorb therapy for sepsisMIB87
Sternal Talon for sternal closure in cardiothoracic surgeryMIB88
Endoscopic transluminal pancreatic necrosectomyHTG421
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fractureHTG422
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesityHTG423
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Nivolumab for previously treated advanced renal cell carcinomaTA417
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Apremilast for treating moderate to severe plaque psoriasisTA419
High-throughput non-invasive prenatal testing for fetal RHD genotypeHTG420
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximabES1
Physical health of people in prisonNG57
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Needle-free arterial non-injectable connectorMIB85
Elbasvir–grazoprevir for treating chronic hepatitis CTA413

Results per page

  1. 10
  2. 25
  3. 50
  4. All